Involvement of SULT1A3 in elevated sulfation of 4-hydroxypropranolol in Hep G2 cells pretreated with beta-naphthoflavone.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biochemical Pharmacology

• Publication date

  2005-03-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BCP.2004.12.012PMID 15748705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Pretreatment of Hep G2 Cells with β-Naphthoflavone on Cytotoxicity of Propranolol and its Active Metabolite 4-Hydroxypropranolol

  2003cited by this paper
• A Problem in the Determination of Trihalomethane by Headspace-Gas Chromatography/Mass Spectrometry

  2003cited by this paper
• Sulfation of environmental estrogens by cytosolic human sulfotransferases.

  2002cited by this paper
• Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements.

  2002cited by this paper
• Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.

  2002cited by this paper
• Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes.

  2002cited by this paper
• Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor alpha gene.

  2002cited by this paper
• Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol.

  2001cited by this paper
• Synthesis of enantiomeric 4-hydroxypropranolols from 1,4-dihydroxynaphthalene

  2001cited by this paper
• High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol.

  2001cited by this paper
• Pharmacogenetics of sulfotransferase.

  2000cited by this paper
• Enzymatic characterization of human cytosolic sulfotransferases; identification of ST1B2 as a thyroid hormone sulfotransferase.

  1999cited by this paper
• Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations.

  1999cited by this paper
• Suicidal inactivation of human dihydropyrimidine dehydrogenase by (E)-5-(2-bromovinyl)uracil derived from the antiviral, sorivudine.

  1998cited by this paper
• Differential regulation of individual sulfotransferase isoforms by phenobarbital in male rat liver.

  1998cited by this paper
• Regulation of sulfotransferase gene expression by glucocorticoid hormones and xenobiotics in primary rat hepatocyte culture.

  1998cited by this paper
• Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.

  1997cited by this paper
• Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones.

  1996cited by this paper
• Regulation of hepatic sulfotransferases by steroidal chemicals in rats.

  1996cited by this paper
• Primary structures and properties of two related forms of aryl sulfotransferases in human liver.

  1995cited by this paper
• Isolation and expression of an isoform of rat estrogen sulfotransferase.

  1995cited by this paper
• Characterization of a chemically reactive propranolol metabolite that binds to microsomal proteins of rat liver.

  1995cited by this paper
• Human phenol sulfotransferases: chiral substrates and expression in Hep G2 cells.

  1994cited by this paper
• Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.

  1994cited by this paper
• Human phenolsulfotransferases: chiral substrates and expression in Hep G2 cells

  1994cited by this paper
• 3-Methylcholanthrene-mediated induction of cytochrome P4501A2 in human hepatoma HepG2 cells as quantified by the reverse transcription-polymerase chain reaction.

  1994cited by this paper
• Stereoselective sulfate conjugation of 4-hydroxypropranolol and terbutaline by the human liver phenolsulfotransferases.

  1992cited by this paper
• Hep G2 cell line as a human model for sulphate conjugation of drugs.

  1992cited by this paper
• Stereoselective sulfate conjugation of racemic 4-hydroxypropranolol by human and rat liver cytosol.

  1991cited by this paper
• Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro.

  1988cited by this paper
• Induction of drug metabolizing enzymes in human liver cell line Hep G2

  1985cited by this paper
• Quantitative account of propranolol metabolism in urine of normal man.

  1985cited by this paper
• Stereochemistry of the in vivo disposition and metabolism of propranolol in dog and man using deuterium-labeled pseudoracemates.

  1985cited by this paper
• Glucuronidation of propranolol by dog liver microsomes. Effects of enantiomeric inhibition and detergent treatment on stereoselectivity.

  1984cited by this paper
• N-dealkylation of propranolol in rat, dog, and man. Chemical and stereochemical aspects.

  1984cited by this paper
• Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

  1982cited by this paper
• A pharmacokinetic analysis program (multi) for microcomputer.

  1981cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Pharmacology of 4‐hydroxypropranolol, a metabolite of propranolol

  1971cited by this paper
• Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.

  1971cited by this paper
• The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias

  1968cited by this paper
• Optical Isomers of Propranolol

  1966cited by this paper

• Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults

  2024cites this paper
• Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD+ production, and AhR activation in autism spectrum disorder

  2023cites this paper
• Human Sulfotransferase Assays With PAPS Production in situ

  2022cites this paper
• MicroRNA Mediated Changes in Drug Metabolism and Target Gene Expression by Efavirenz and Rifampicin In Vitro: Clinical Implications

  2019cites this paper
• On the sulfation of O-desmethyltramadol by human cytosolic sulfotransferases

  2017cites this paper
• Sulfation of 6-hydroxymelatonin, N-acetylserotonin and 4-hydroxyramelteon by the human cytosolic sulfotransferases (SULTs)

  2016influential citation
• Identification of the Human SULT Enzymes Involved in the Metabolism of Rotigotine

  2016cites this paper
• Human Cytosolic Sulfotransferase SULT1A3 Mediates the Sulfation of Dextrorphan.

  2016cites this paper
• Sulfation of 6-Gingerol by the Human Cytosolic Sulfotransferases: A Systematic Analysis

  2015cites this paper
• Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis.

  2015cites this paper
• Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis.

  2014cites this paper
• Concerted actions of the catechol O-methyltransferase and the cytosolic sulfotransferase SULT1A3 in the metabolism of catecholic drugs.

  2012cites this paper
• Sulfation of ractopamine and salbutamol by the human cytosolic sulfotransferases.

  2012cites this paper
• The development of improved and new in vitro assays for detecting the genotoxic and non-genotoxic carcinogenic potential of chemicals in the discovery phase of drug development

  2011influential citation
• Expression levels of drug-metabolizing enzyme, transporter, and nuclear receptor mRNAs in a novel three-dimensional culture system for human hepatocytes using micro-space plates.

  2011cites this paper
• Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies.

  2008cites this paper
• Comparison of inducibility of sulfotransferase and UDP-glucuronosyltransferase mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes.

  2008cites this paper
• Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.

  2007cites this paper
• Induction of human sulfotransferase 1A3 (SULT1A3) by glucocorticoids.

  2007cites this paper
• Principles of Drug Metabolism 2: Hydrolysis and Conjugation Reactions

  2007cites this paper
• Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.

  2007cites this paper
• Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes.

  2006cites this paper
• Evaluation of mRNA expression of human drug-metabolizing enzymes and transporters in chimeric mouse with humanized liver

  2005cites this paper